Analyst Price Targets — HOLX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| November 21, 2025 10:08 am | — | BNP Paribas | $79.00 | $74.12 | TheFly | Hologic downgraded to Neutral from Outperform at BNP Paribas Exane |
| October 23, 2025 9:49 am | — | Mizuho Securities | $78.00 | $73.93 | TheFly | Hologic downgraded to Neutral from Outperform at Mizuho |
| October 22, 2025 1:31 pm | — | Stephens | $76.00 | $74.01 | TheFly | Hologic downgraded to Equal Weight from Overweight at Stephens |
| October 21, 2025 5:37 pm | — | Leerink Partners | $78.00 | $74.08 | TheFly | Hologic price target raised to $78 from $70 at Leerink |
| October 7, 2025 10:10 am | Vijay Kumar | Evercore ISI | $78.00 | $67.34 | TheFly | Hologic upgraded to Outperform from In Line at Evercore ISI |
| July 31, 2025 11:15 am | — | Mizuho Securities | $75.00 | $64.98 | TheFly | Hologic price target raised to $75 from $70 at Mizuho |
| May 5, 2025 11:25 am | Tejas Savant | Morgan Stanley | $65.00 | $52.73 | TheFly | Hologic price target lowered to $65 from $77 at Morgan Stanley |
| November 5, 2024 11:39 am | Anthony Petrone | Mizuho Securities | $87.00 | $78.80 | StreetInsider | Hologic (HOLX) PT Lowered to $87 at Mizuho |
| October 4, 2024 9:15 am | Anthony Petrone | Mizuho Securities | $90.00 | $79.63 | TheFly | Hologic price target raised to $90 from $85 at Mizuho |
| October 1, 2024 6:01 am | Patrick Donnelly | Citigroup | $85.00 | $81.46 | TheFly | Hologic downgraded to Neutral from Buy at Citi |
Latest News for HOLX
GE HealthCare is gaining ground with strong backlog, AI-driven imaging advances and rising service capture, while Hologic's buyout caps near-term upside.
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
Citigroup Inc. decreased its holdings in shares of Hologic, Inc. (NASDAQ: HOLX) by 13.0% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,136,662 shares of the medical equipment provider's stock after selling 170,451 shares during the period. Citigroup Inc. owned approximately 0.51% of
Hologic, Inc. (NASDAQ: HOLX - Get Free Report)'s share price reached a new 52-week high on Friday. The stock traded as high as $75.39 and last traded at $75.3550, with a volume of 703846 shares trading hands. The stock had previously closed at $75.14. Wall Street Analysts Forecast Growth HOLX has been the subject of
Insights from the Fourth Quarter 2025 13F Filing Joel Greenblatt (Trades, Portfolio) recently submitted the 13F filing for the fourth quarter of 2025, providin
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.